Grifols Sa Stock Fundamentals
OZTA Stock | EUR 10.32 0.22 2.09% |
Grifols SA fundamentals help investors to digest information that contributes to Grifols SA's financial success or failures. It also enables traders to predict the movement of Grifols Stock. The fundamental analysis module provides a way to measure Grifols SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Grifols SA stock.
Grifols |
Grifols SA Company Return On Equity Analysis
Grifols SA's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Grifols SA Return On Equity | 0.0182 |
Most of Grifols SA's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Grifols SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Based on the latest financial disclosure, Grifols SA has a Return On Equity of 0.0182. This is 100.08% lower than that of the Healthcare sector and 99.15% lower than that of the Drug Manufacturers - Major industry. The return on equity for all Germany stocks is 105.87% lower than that of the firm.
Grifols SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Grifols SA's current stock value. Our valuation model uses many indicators to compare Grifols SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Grifols SA competition to find correlations between indicators driving Grifols SA's intrinsic value. More Info.Grifols SA is regarded fourth in return on equity category among its peers. It also is regarded fourth in return on asset category among its peers reporting about 0.85 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Grifols SA is roughly 1.17 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Grifols SA's earnings, one of the primary drivers of an investment's value.Grifols Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Grifols SA's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Grifols SA could also be used in its relative valuation, which is a method of valuing Grifols SA by comparing valuation metrics of similar companies.Grifols SA is currently under evaluation in return on equity category among its peers.
Grifols Fundamentals
Return On Equity | 0.0182 | |||
Return On Asset | 0.0155 | |||
Profit Margin | 0.01 % | |||
Operating Margin | 0.09 % | |||
Current Valuation | 15.22 B | |||
Shares Outstanding | 422.18 M | |||
Shares Owned By Insiders | 30.57 % | |||
Shares Owned By Institutions | 30.74 % | |||
Price To Earning | 34.97 X | |||
Price To Book | 1.06 X | |||
Price To Sales | 1.22 X | |||
Revenue | 4.93 B | |||
Gross Profit | 1.96 B | |||
EBITDA | 944.03 M | |||
Net Income | 182.8 M | |||
Cash And Equivalents | 554.43 M | |||
Cash Per Share | 0.81 X | |||
Total Debt | 6.1 B | |||
Debt To Equity | 143.00 % | |||
Current Ratio | 2.68 X | |||
Book Value Per Share | 9.32 X | |||
Cash Flow From Operations | 596.98 M | |||
Earnings Per Share | 0.09 X | |||
Price To Earnings To Growth | 0.55 X | |||
Number Of Employees | 27.58 K | |||
Beta | 0.48 | |||
Market Capitalization | 7.46 B | |||
Total Asset | 19.23 B | |||
Z Score | 0.6 | |||
Annual Yield | 0.02 % | |||
Five Year Return | 1.41 % | |||
Net Asset | 19.23 B |
About Grifols SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Grifols SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Grifols SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Grifols SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Grifols, S.A., a specialty pharmaceutical company, develops, manufactures, and distributes a range of biological medicines on plasma derived proteins worldwide. The company was founded in 1940 and is headquartered in Barcelona, Spain. GRIFOLS SA operates under Drug Manufacturers - Major classification in Germany and is traded on Frankfurt Stock Exchange. It employs 22282 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Grifols Stock
Grifols SA financial ratios help investors to determine whether Grifols Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Grifols with respect to the benefits of owning Grifols SA security.